Literature DB >> 15668561

Pigmented villonodular synovitis: an uncommon presentation of anterior hip pain.

David Spanier1, Mark Harrast.   

Abstract

Pigmented villonodular synovitis (PVNS) is a rare, benign, idiopathic proliferative disorder of the synovium that results in villous or nodular formation in joints, tendon sheaths, and bursae. The disease can be localized or diffuse. Its estimated prevalence is 1.8 cases per million in the United States. Large joints, such as the knee and hip, are commonly affected. Patients with this condition typically present with symptoms of mild discomfort and associated stiffness of the involved joint; however, the spectrum of presentations is broad. We present a case of an otherwise healthy 40-yr-old man who presented for evaluation of stiffness and pain in the anterior hip. His initial presentation, work-up, and course will be discussed, along with a brief review of the literature.

Entities:  

Mesh:

Year:  2005        PMID: 15668561     DOI: 10.1097/01.phm.0000150794.33166.3a

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  4 in total

1.  Arthroscopic treatment of localized pigmented villonodular synovitis of the knee.

Authors:  Philippe Loriaut; Patrick Djian; Thierry Boyer; Jean-Paul Bonvarlet; Cyrille Delin; Konstantinos G Makridis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-12       Impact factor: 4.342

2.  Localized nodular pigmented villonodular synovitis of the upper ankle joint--diagnosis and treatment.

Authors:  B Ganse; P Behrens; J Gellissen; S Krüger; J P Benthien
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

3.  Pigmented villonodular synovitis responsive to imatinib therapy.

Authors:  Wynne M Snoots; David Watkins; Dee Dockery; Robert Mennel; Brennen Scott Cheek
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

4.  Pediatric pigmented villonodular synovitis mimicking a septic hip.

Authors:  Aarat M Patel; Amanda G Brown; Csaba Galambos; Raphael Hirsch
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.